Yoon‐La Choi

20.9k total citations
288 papers, 8.3k citations indexed

About

Yoon‐La Choi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yoon‐La Choi has authored 288 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Pulmonary and Respiratory Medicine, 139 papers in Oncology and 87 papers in Molecular Biology. Recurrent topics in Yoon‐La Choi's work include Lung Cancer Treatments and Mutations (97 papers), Lung Cancer Research Studies (49 papers) and Cancer Genomics and Diagnostics (48 papers). Yoon‐La Choi is often cited by papers focused on Lung Cancer Treatments and Mutations (97 papers), Lung Cancer Research Studies (49 papers) and Cancer Genomics and Diagnostics (48 papers). Yoon‐La Choi collaborates with scholars based in South Korea, United States and China. Yoon‐La Choi's co-authors include Myung‐Ju Ahn, Jin Seok Ahn, Keunchil Park, Jong‐Mu Sun, Joungho Han, Se‐Hoon Lee, Young Kee Shin, Young Tae Kim, Woong‐Yang Park and Mao Mao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Yoon‐La Choi

279 papers receiving 8.1k citations

Peers

Countries citing papers authored by Yoon‐La Choi

Since Specialization

Citations

This map shows the geographic impact of Yoon‐La Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon‐La Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon‐La Choi more than expected).

Fields of papers citing papers by Yoon‐La Choi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon‐La Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon‐La Choi. The network helps show where Yoon‐La Choi may publish in the future.

Co-authorship network of co-authors of Yoon‐La Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon‐La Choi. A scholar is included among the top collaborators of Yoon‐La Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon‐La Choi. Yoon‐La Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Harnessing Extracellular Vesicles for Targeted Drug Delivery in Ovarian Cancer 2025 ·Pharmaceutics ·Jang‐Hyuk Yun, (unknown), (unknown), Soo-Hyun Park, Yoon‐La Choi, (unknown), Iljin Kim	2
2	The Growth of Screening-Detected Pure Ground-Glass Nodules Following 10 Years of Stability 2024 ·CHEST Journal ·Bo‐Guen Kim, (unknown), (unknown), Yoon‐La Choi, Jung Hye Hwang, Ho Yun Lee, (unknown), Sun Hye Shin, Byeong‐Ho Jeong, Kyungjong Lee, Hojoong Kim, Hong Kwan Kim, Sang‐Won Um	2
3	Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer 2024 ·EBioMedicine ·Sehhoon Park, Tae Hee Hong, Soohyun Hwang, Simon Heeke, Carl M. Gay, Jiyeon Kim, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Jong Ho Cho, Yong Soo Choi, Jhingook Kim, Young Mog Shim, Hong Kwan Kim, Lauren A. Byers, John V. Heymach, Yoon‐La Choi, Se‐Hoon Lee, Keunchil Park	22
4	Genomic landscape and therapeutic implications in advanced solid cancers: KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors, KCSG AL-22-09). 2024 ·Journal of Clinical Oncology ·Heejung Chae, Harim Koo, Sun Young Kim, Sook Ryun Park, Shinkyo Yoon, Min‐Hee Ryu, Soo Hyun Lee, Tae Yong Kim, Tae‐Min Kim, Sae‐Won Han, Se‐Hoon Lee, Hyun Ae Jung, (unknown), Minkyu Jung, Gyeong‐Won Lee, Mi Sun Ahn, Hongseok Yun, Yoon‐La Choi, Sejoon Lee, Jee Hyun Kim	0
5	Clinical Course of Patients With Mediastinal Lymph Node Tuberculosis and Risk Factors for Paradoxical Responses 2023 ·Journal of Korean Medical Science ·(unknown), (unknown), Sun Hye Shin, Kyungjong Lee, Sang‐Won Um, Hojoong Kim, (unknown), Hee Jae Huh, Yoon‐La Choi, Joungho Han, Byeong‐Ho Jeong	0
6	Evaluation of MET alteration in EGFR-mutant non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor from paired biopsy: A retrospective cohort study 2022 ·SHILAP Revista de lepidopterología ·Bo Mi Ku, (unknown), Sehhoon Park, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Yoon‐La Choi, Myung‐Ju Ahn	1
7	The High Proportion of Discordant EGFR Mutations among Multiple Lung Tumors 2022 ·Cancers ·Hyunwoo Lee, Jin Hee Park, Joungho Han, Young Mog Shim, Young Tae Kim, Yong Soo Choi, Hong Kwan Kim, Jong Ho Cho, Yoon‐La Choi, Wan Seop Kim	4
8	PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score 2021 ·Cancers ·Yoon Ah Cho, Hyunwoo Lee, (unknown), Hyunjin Kim, Sang Yun Ha, Yoon‐La Choi, Kee‐Taek Jang, Kyoung‐Mee Kim	36
9	Radial neuropathy caused by intraneural leiomyoma 2020 ·Medicine ·(unknown), Hyunjin Kim, Yoon‐La Choi, Byung‐Joon Jeon, Duk Hyun Sung	1
10	Dysregulation of cancer genes by recurrent intergenic fusions 2020 ·Genome biology ·Jae Won Yun, Lixing Yang, Hye-Young Park, Chang‐Woo Lee, Hongui Cha, Hyun‐Tae Shin, Ka‐Won Noh, Yoon‐La Choi, Woong‐Yang Park, Peter J. Park	25
11	Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer 2020 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), Jihye Nam, Kyungsoo Jung, Woo Sung Son, Hun Jung, Jong‐Hwa Lee, Seong Hoon Jeong, Nam Ah Kim, Jae Du Ha, Sung Yun Cho, Yoon‐La Choi, Suk‐Jae Chung, Jun Yong Choi, (unknown), Young Kee Shin	11
12	An Immune–Magnetophoretic Device for the Selective and Precise Enrichment of Circulating Tumor Cells from Whole Blood 2020 ·Micromachines ·Chaithanya Chelakkot, Jiyeon Ryu, Mi Young Kim, Jin‐Soo Kim, (unknown), (unknown), Sung Hoon Park, (unknown), Jeong Won Park, Moon Youn Jung, Ryong Nam Kim, Kyoung Song, Yu Jin Kim, Yoon‐La Choi, (unknown), Young Kee Shin	13
13	Benefit of Targeted DNA Sequencing in Advanced Non–Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests 2019 ·Clinical Lung Cancer ·Seonggyu Byeon, Boram Lee, Woong‐Yang Park, Yoon‐La Choi, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Se‐Hoon Lee	7
14	Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK -Rearranged NSCLC 2018 ·Clinical Cancer Research ·Ka‐Won Noh, Insuk Sohn, Ji‐Young Song, (unknown), Yu‐Jin Kim, Kyungsoo Jung, (unknown), Mingi Kim, (unknown), Joungho Han, Se‐Hoon Lee, Mi‐Sook Lee, Yoon‐La Choi	17
15	Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors 2018 ·Journal of Korean Medical Science ·Jongmin Sim, Hyunjin Kim, Jiyeon Hyeon, Yoon‐La Choi, Joungho Han	5
16	Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion 2015 ·Journal of Clinical Pathology ·Ji‐Youn Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, (unknown), Han Yong Choi, So Young Kang, Yoon‐La Choi, Ghee Young Kwon	14
17	Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows Potent In Vitro Antitumor Activity in Gastric Cancer Cell Lines with FGFR2 Amplification 2014 ·Molecular Cancer Therapeutics ·Seung Tae Kim, (unknown), Su Jin Lee, Jeeyun Lee, Yoon‐La Choi, Kyoung‐Mee Kim, Jeonghee Cho, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Masakazu Yashiro, Won Ki Kang, Joon Oh Park	35
18	Identification of prognostic biomarkers for glioblastomas using protein expression profiling 2011 ·International Journal of Oncology ·Yong Jin Jung, Kyeung Min Joo, (unknown), Yoon‐La Choi, Doo‐Sik Kong, Yonghyun Kim, Mi‐Hyun Kim, Juyoun Jin, (unknown), Ho Jun Seol, Chul Soo Shin, Jung-Il Lee, Jong-Hyun Kim, Sang Yong Song, Do‐Hyun Nam	19
19	Clinical Significance of CD99 Down-Regulation in Gastric Adenocarcinoma 2007 ·Clinical Cancer Research ·Jung Hyun Lee, Seok-Hyung Kim, Lihui Wang, Yoon‐La Choi, Young Chul Kim, Jin Hee Kim, Tae Sung Park, Yun‐Chul Hong, Young Kee Shin	26
20	Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression 2007 ·Clinical Cancer Research ·Lihui Wang, (unknown), Jung Hyun Lee, Yoon‐La Choi, Young Chul Kim, Tae Sung Park, Yun‐Chul Hong, Chunfu Wu, Young Kee Shin	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact